Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00063531 · ClinicalTrials.gov registry record

Comparison of Two Methods to Diagnose Coronary Artery Disease

A clinical trial of Cardiovascular Diseases and Heart Diseases, sponsored by Johns Hopkins University.

Completed
Registry status
650
Enrollment target
1
Study location

NCT00063531: Completed study of Cardiovascular Diseases and Heart Diseases, sponsored by Johns Hopkins University.

NCT00063531 is a study of Cardiovascular Diseases and Heart Diseases that has completed, run by Johns Hopkins University. The registered enrollment target is 650 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00063531, a study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
650 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare two methods of diagnosing coronary artery disease (CAD), thallium single photon emission computed tomography (SPECT) and ultrafast computed tomography (CT).

Primary Outcome

The question to be answered is what percentage of healthy people with a family history of early onset CAD in a sibling have only non-calcified coronary artery plaque that would not be detected by coronary calcium imaging. How much additional information is provided by CTA?

Study Locations (1)

Maryland

  • Johns Hopkins University School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2003-06
Est. Completion 2007-01
Johns Hopkins University

1,448 total trials

What the finished NCT00063531 record still lists

NCT00063531 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00063531 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00063531 about?

NCT00063531 is a clinical study titled "Comparison of Two Methods to Diagnose Coronary Artery Disease". The purpose of this study is to compare two methods of diagnosing coronary artery disease (CAD), thallium single photon emission computed tomography (SPECT) and ultrafast computed tomography (CT).

What is the current status of trial NCT00063531?

This trial is currently completed. The enrollment target is 650 participants. The study started on 2003-06. Estimated completion is 2007-01.

What conditions does trial NCT00063531 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Coronary Disease.

Who is sponsoring clinical trial NCT00063531?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00063531 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00063531's enrollment target sits among peer trials

650 81st of 300 higher than 218 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02934477 · 650 participants

    Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

  • NCT04579120 · 650 participants

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

  • NCT04875702 · 650 participants · Phase 4

    Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

  • NCT05046600 · 650 participants

    Registry of Arthrex Hand and Wrist Products

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00063531, the US trial registry maintained by the National Library of Medicine. NCT00063531 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.